Riichiroh Maruyama

Summary

Affiliation: National Kyushu Cancer Center
Country: Japan

Publications

  1. ncbi Triplet chemotherapy for malignant pericardial mesothelioma: a case report
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, 3 1 1 Notame, Minami Ku, Fukuoka 811 1395, Japan
    Jpn J Clin Oncol 36:245-8. 2006
  2. ncbi Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution
    Riichiroh Maruyama
    Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
    J Thorac Cardiovasc Surg 127:1587-92. 2004
  3. ncbi Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma
    Riichiroh Maruyama
    Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Cancer 100:1472-7. 2004
  4. ncbi Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: a multi-institutional phase II trial
    Riichiroh Maruyama
    Kyushu Yamaguchi Thoracic Oncology Group, Kyushu Cancer Center, Minami Ku, Fukuoka, Japan
    J Thorac Oncol 2:65-8. 2007
  5. ncbi Establishment of a clinical pathway as an effective tool to reduce hospitalization and charges after video-assisted thoracoscopic pulmonary resection
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Jpn J Thorac Cardiovasc Surg 54:387-90. 2006
  6. ncbi Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, 3 1 1 Notame, Minami Ku, Fukuoka 811 1395, Japan
    Jpn J Clin Oncol 35:433-8. 2005
  7. ncbi Initial experience with video-assisted thoracoscopic surgery for pulmonary metastasis in the prone position
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Surg Laparosc Endosc Percutan Tech 16:117-8. 2006
  8. ncbi Long-term survivors in stage IV non-small cell lung cancer
    Tatsuro Okamoto
    Department of Thoracic Oncology, National Kyushu Cancer Center, 3 1 1, Notame, Minami Ku, Fukuoka 811 1395, Japan
    Lung Cancer 47:85-91. 2005
  9. ncbi Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, 3 1 1 Notame, Minami Ku, Fukuoka, 811 1395, Japan
    Surg Today 41:1492-7. 2011
  10. ncbi Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer
    Shinichi Toyooka
    Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas TX 75390-8593, USA
    Int J Cancer 103:153-60. 2003

Detail Information

Publications41

  1. ncbi Triplet chemotherapy for malignant pericardial mesothelioma: a case report
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, 3 1 1 Notame, Minami Ku, Fukuoka 811 1395, Japan
    Jpn J Clin Oncol 36:245-8. 2006
    ..The patient has returned to her usual activities and has remained well for 24 months after the last chemotherapy without any evidence of disease progression...
  2. ncbi Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution
    Riichiroh Maruyama
    Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
    J Thorac Cardiovasc Surg 127:1587-92. 2004
    ....
  3. ncbi Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma
    Riichiroh Maruyama
    Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Cancer 100:1472-7. 2004
    ..The purpose of the current study was to determine the correlation between the aberrant promoter methylation of multiple genes and survival in patients with nonsmall cell lung carcinoma (NSCLC)...
  4. ncbi Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: a multi-institutional phase II trial
    Riichiroh Maruyama
    Kyushu Yamaguchi Thoracic Oncology Group, Kyushu Cancer Center, Minami Ku, Fukuoka, Japan
    J Thorac Oncol 2:65-8. 2007
    ..The effect of pericardial drainage and the intra-pericardial instillation of bleomycin on the control of MPE was examined in this prospective multi-institutional phase II trial...
  5. ncbi Establishment of a clinical pathway as an effective tool to reduce hospitalization and charges after video-assisted thoracoscopic pulmonary resection
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Jpn J Thorac Cardiovasc Surg 54:387-90. 2006
    ..The purpose of this study was to assess the effect of establishing a clinical pathway based on the length of hospitalization, hospital charges, and the outcome for video-assisted thoracoscopic pulmonary resection (VATPR)...
  6. ncbi Triplet chemotherapy with cisplatin, gemcitabine and vinorelbine for malignant pleural mesothelioma
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, 3 1 1 Notame, Minami Ku, Fukuoka 811 1395, Japan
    Jpn J Clin Oncol 35:433-8. 2005
    ..We investigated the use of triplet combination chemotherapy with cisplatin (CDDP), gemcitabine (GEM) and vinorelbine (VNR) for the treatment of Japanese patients with MPM...
  7. ncbi Initial experience with video-assisted thoracoscopic surgery for pulmonary metastasis in the prone position
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Surg Laparosc Endosc Percutan Tech 16:117-8. 2006
    ..In cases where the lateral decubitus position cannot be used, the prone position is both safe and effective for treating dorsal lesions of the lung by means of video-assisted thoracoscopic surgery...
  8. ncbi Long-term survivors in stage IV non-small cell lung cancer
    Tatsuro Okamoto
    Department of Thoracic Oncology, National Kyushu Cancer Center, 3 1 1, Notame, Minami Ku, Fukuoka 811 1395, Japan
    Lung Cancer 47:85-91. 2005
    ..To determine the prognostic factors for long-term survivors (LTS) with stage IV non-small cell lung cancer (NSCLC) who had undergone various treatments...
  9. ncbi Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, 3 1 1 Notame, Minami Ku, Fukuoka, 811 1395, Japan
    Surg Today 41:1492-7. 2011
    ..This single-institutional study was designed to determine whether S-1, an oral fluoropyrimidine, plus cisplatin with concurrent radiotherapy is feasible as an induction treatment for locally advanced non-small cell lung cancer (NSCLC)...
  10. ncbi Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer
    Shinichi Toyooka
    Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas TX 75390-8593, USA
    Int J Cancer 103:153-60. 2003
    ..Our findings demonstrate important smoke exposure, histologic type and geography-related differences in the methylation profiles of NSCLC tumors...
  11. ncbi Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Oncology 70:325-9. 2006
    ..CONCLUSION: The doublet of CBDCA and paclitaxel thus appears to be a promising regimen for TC and further investigation in a multi-institutional phase II trial is, therefore, strongly called for...
  12. ncbi Clinical patterns and treatment outcome of elderly patients in clinical stage IB/II non-small cell lung cancer
    Tatsuro Okamoto
    Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
    J Surg Oncol 87:134-8. 2004
    ..To better manage such elderly patients, the clinical characteristics and prognosis of patients with these stages, who were 75 years of age or older, were reviewed...
  13. ncbi Multiple pulmonary metastases of lung adenocarcinoma to a different ipsilateral lobe after pulmonary lobectomy
    Tatsuro Okamoto
    Department of Thoracic Oncology, National Kyushu Cancer Center, 3 1 1 Notame, Minami Ku, Fukuoka 811 1395, Japan
    Lung Cancer 56:449-53. 2007
    ....
  14. ncbi Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer
    Jiro Ikeda
    Department of Thoracic Oncology, National Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka 811-1395, Japan
    Jpn J Clin Oncol 36:12-6. 2006
    ..A partial response was observed in 4 of 15 patients (27%). CONCLUSIONS: The recommended dose was thus determined to be 25 mg/m(2) amrubicin with 20 mg/m(2) cisplatin for 3 consecutive days. A phase II study is currently underway...
  15. ncbi Hepatic lesion of invasive thymoma: possibility of direct invasion
    Tatsuro Okamoto
    Department of Thoracic Oncology, National Kyushu Cancer Center, Notame 3 1 1, Minami Ku, Fukuoka, 811 1395, Japan
    Int J Clin Oncol 12:300-2. 2007
    ..Appropriate local control in the early stages of the clinical course may therefore be essential for preventing the extrathoracic spread of invasive thymoma...
  16. ncbi Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinum
    Takashi Seto
    Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
    J Thorac Oncol 3:637-42. 2008
    ....
  17. ncbi Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features
    Ubaradka G Sathyanarayana
    Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8593, USA
    Clin Cancer Res 9:6395-400. 2003
    ..These findings are of biological interest and potentially of clinical importance...
  18. ncbi Serum carcinoembryonic antigen as a predictive marker for sensitivity to gefitinib in advanced non-small cell lung cancer
    Tatsuro Okamoto
    Department of Thoracic Oncology, National Kyushu Cancer Center, 3 1 1 Notame, Fukuoka 811 1395, Japan
    Eur J Cancer 41:1286-90. 2005
    ..These data show that the serum CEA level can be a predictive factor for the efficacy of gefitinib treatment while it is also a prognostic factor for advanced NSCLC patients undergoing this treatment...
  19. ncbi Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes
    Ubaradka G Sathyanarayana
    Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390-8593, USA
    Cancer Res 64:1425-30. 2004
    ..Of particular interest, methylation frequencies of LAMA3 helped to distinguish invasive (72%) from noninvasive (12%) tumors. These results suggest that methylation of LN5 genes has potential clinical applications in bladder cancers...
  20. ncbi A unique method for repairing intraoperative pulmonary air leakage with both polyglycolic acid sheets and fibrin glue
    Tokujiro Yano
    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3 1 1, Higashi ku, Fukuoka, 812 8582, Japan
    World J Surg 36:463-7. 2012
    ..In the present study we present a unique maneuver, using both fibrin glue and polyglycolic acid (PGA) sheets, for repairing intraoperative pulmonary air leakage, and report our clinical results...
  21. ncbi Prognostic factors in previously treated non-small cell lung cancer patients with and without a positive response to the subsequent treatment with gefitinib
    Hiroshi Wataya
    Department of Thoracic Oncology, National Kyushu Cancer Center, Notame 3 1 1, Minami Ku, Fukuoka 811 1395, Japan
    Lung Cancer 64:341-5. 2009
    ..The effectiveness of the first-line chemotherapy was therefore found to be a prognostic factor in the gefitinib responders with previously treated NSCLC, while the PS was shown to be a prognostic factor in the gefitinib non-responders...
  22. ncbi Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer
    Kensaku Ito
    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3 1 1, Higashi ku, Fukuoka 812 8582, Japan
    Anticancer Res 32:1063-7. 2012
    ..In the present study, we examined the status of oxidative stress and attempted to clarify the influence of oxidative stress in non-smoking patients with lung cancer...
  23. ncbi Treatment after the failure of gefitinib in patients with advanced or recurrent non-small cell lung cancer
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Anticancer Res 29:4217-21. 2009
    ..The optimal treatment for patients with progressive non-small cell lung cancer who initially show a good response to gefitinib is unclear...
  24. ncbi Pulmonary typical carcinoid tumor and liver metastasis with hypermetabolism on 18-fluorodeoxyglucose PET: a case report
    Ryuichi Suemitsu
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Ann Thorac Cardiovasc Surg 14:109-11. 2008
    ..Thereafter he underwent partial resection of he liver mass, and the histology was metastasis from pulmonary carcinoid. We first reported a typical pulmonary carcinoid that showed high FDG uptake at the primary site and liver metastasis...
  25. ncbi A long-term survivor after aggressive treatment for tracheal adenoid cystic carcinoma: a case report
    Ryuichi Suemitsu
    Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
    Ann Thorac Cardiovasc Surg 13:335-7. 2007
    ..Although the patient had five instances of recurrence over an 11-year period during his treatment course, he is presently doing well as a result of appropriate local treatments using multiple modalities...
  26. ncbi [Interstitial pneumonitis]
    Fumihiko Hirai
    Dept of Thoracic Oncology, National Kyushu Cancer Center, Japan
    Gan To Kagaku Ryoho 38:1782-4. 2011
    ..It is necessary to decrease the risk of interstitial pneumonitis by several steps, cooperating with an entire medical staff...
  27. ncbi Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features
    Tokujiro Yano
    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3 1 1, Higashi ku, Fukuoka, 812 8582, Japan
    Int J Clin Oncol 16:287-93. 2011
    ..In consideration of the future increase in never-smoking NSCLC or 'non-smoking-associated lung cancer', both clinical trials and investigations are needed...
  28. ncbi Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines
    Kenichi Harada
    Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, TX 75390, USA
    Oncogene 21:4345-9. 2002
    ..In five of six cell lines, restoration of RASSF1A mRNA was confirmed by RT-PCR. Our findings indicate that aberrant promoter methylation of RASSF1A may contribute to the pathogenesis of many different forms of pediatric tumors...
  29. ncbi Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer
    Tokujiro Yano
    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    J Surg Oncol 102:852-5. 2010
    ....
  30. ncbi Intrathoracic omental herniation through the esophageal hiatus in a young patient
    Riichiroh Maruyama
    Department of Thoracic Oncology, Kyushu Cancer Center, Fukuoka, Japan
    Jpn J Thorac Cardiovasc Surg 53:452-4. 2005
    ..This is the first report of omental herniation through the esophageal hiatus in a patient still in his twenties...
  31. ncbi Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer
    Riichiroh Maruyama
    National Kyushu Cancer Center, Fukuoka, Japan
    J Clin Oncol 26:4244-52. 2008
    ..This phase III study (V-15-32) compared gefitinib (250 mg/d) with docetaxel (60 mg/m(2)) in patients (N = 489) with advanced/metastatic non-small-cell lung cancer (NSCLC) who had failed one or two chemotherapy regimens...
  32. ncbi Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation
    Asha Padar
    Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Clin Cancer Res 9:4730-4. 2003
    ..We investigated the epigenetic silencing of Cyclin D2 gene in prostate cancers and correlated the data with clinicopathological features...
  33. ncbi Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women
    Asha Rathi
    Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75930, USA
    Clin Cancer Res 8:3324-31. 2002
    ..CONCLUSIONS: Our results suggest that aberrant methylation of specific genes, including two not described previously, may be important in ovarian cancer pathogenesis but not in ovaries at risk for cancer development...
  34. ncbi BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression
    Yosuke Morodomi
    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Mol Ther 20:769-77. 2012
    ..Therefore, these results suggest a proof of concept that the tumor cell-killing mechanism via BioKnife may have significant potential to treat patients with MPM that is characterized by frequent uPAR expression in a clinical setting...
  35. ncbi Differences in the expression of epithelial-mesenchymal transition related molecules between primary tumors and pulmonary metastatic tumors in colorectal cancer
    Hidenori Kouso
    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3 1 1 Maidashi, Higashi ku, Fukuoka 812 8582, Japan
    Surg Today 43:73-80. 2013
    ..This study immunohistochemically examined the expression of EMT-related molecules in both primary colorectal cancer and pulmonary metastases, and analyzed the expression pattern...
  36. ncbi Localized pleural amyloidosis: report of a case
    Shohei Yoshiya
    Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3 1 1 Maidashi, Higashi ku, Fukuoka, Japan
    Surg Today 42:597-600. 2012
    ..We therefore carried out a thoracoscopy-assisted partial resection of the right upper lobe combined with a parietal pleurectomy. The pathological examination showed that there was a tumor localized with pleural amyloidosis...
  37. ncbi Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features
    Riichiroh Maruyama
    Hamon Center for Therapeutic Oncology Research, Department of Pathology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA
    Clin Cancer Res 8:514-9. 2002
    ..We investigated the aberrant methylation profile of prostate cancers and correlated the data with clinical findings...
  38. ncbi Extraskeletal osteosarcoma of the pleura: a case report
    Rumi Matono
    Department of Surgery, Nippon Steel Yawata Memorial Hospital, 1 1 1 Harunomachi, Yahatahigashi ku, Kitakyushu, 805 8508, Japan
    Gen Thorac Cardiovasc Surg 56:180-2. 2008
    ..The resected tumor was histologically an osteosarcoma, measuring 11.3 x 9.0 x 6.0 cm. Because there was no evidence of any other primary tumor, the diagnosis of extraskeletal osteosarcoma was appropriate...
  39. ncbi Feasibility trial of adjuvant chemotherapy with paclitaxel and carboplatin after surgical resection in Japanese patients with non-small cell lung cancer: report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0501
    Riichiroh Maruyama
    Department of Surgery, Nippon Steel Yawata Memorial Hospital, 1 1 1 Harunomachi, Yahatahigashi ku, Kitakyushu 805 8508, Japan
    Gen Thorac Cardiovasc Surg 56:68-73. 2008
    ....
  40. ncbi Dose effect of smoking on aberrant methylation in non-small cell lung cancers
    Shinichi Toyooka
    Int J Cancer 110:462-4. 2004
  41. ncbi Intrathoracic ganglioneuroma in an elderly patient over 70 years of age
    Riichiroh Maruyama
    Department of Surgery, Nippon Steel Yawata Memorial Hospital, 1 1 1 Harunomachi, Yahatahigashi ku, Kitakyushu 805 8508, Japan
    Gen Thorac Cardiovasc Surg 55:437-9. 2007
    ..Not only tumors originating from the nerve sheath, but also neurogenic tumors occurring in young patients such as ganglioneuroma, should be included in the different diagnosis of posterior mediastinal tumor occurring in elderly patients...